APP2024: the top 20
APP chairman Kos Sclavos lists his top 20 must-see events and sessions at the upcoming conference Each year, APP c18hairman Kos Sclavos AM is asked to share his top APP …
The case for importing
Taking expensive medicines or ones unavailable in Australia? Importing may be the answer, write Jacinta Johnson and Kirsten Staff The cost-of-living crisis may be driving some Australians to look for …
Administering medicines by injection
PDL offers some timely advice on some of the risks and areas to focus on when administering medicines by injection In recent years, the pharmacy profession has seen significant expansion …
Pharmacy partnerships: how do you make them work?
A pharmacy partnership can be like a marriage, with hard work you can navigate the challenges and find the solutions, says John Thornett It is often said that partnerships are …
It’s 4 years since the first COVID case in Australia
Here’s how our pandemic experiences have changed over time, writes Deborah Lupton from UNSW Sydney It might be hard to believe, but four years have now passed since the first …
Are discount models detrimental?
Melbourne pharmacist Pardeep Singh takes aim at the discount model, arguing it has negative impacts for patients and the profession I’m curious if anyone is aware of any ‘discount petrol …
A blunder many pharmacies make
Are your marketing campaigns working for your pharmacy? If they’re not, then there may be one crucial mistake you’re making, says Sarah Rendell I recently had a catch up with …
E-scripts: three key incident types
In its last practice update for 2023, PDL has some advice regarding electronic prescriptions The introduction of electronic prescriptions has improved patient accessibility to medication and reduced the administrative burden …
National vacancy for Professional Officer
PDL is looking for a new face on its team of Professional Officers Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy …
Another variant vaccine, another potential risk
With the availability of the latest Pfizer (Comirnaty) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration error, writes PDL This is …
The year’s weirdest science stories: 2023
It’s been an interesting year in pharmacy, and more widely, in the world of science. Dr Joe Milton of the Australian Science Media Centre presents its 10 weirdest stories of …
Credentialed pharmacists come together in Cairns
Credentialed pharmacists and those interested in this growing area of practice have a new opportunity to tackle the issues, writes Sarah Gillespie Following the overwhelming success of the inaugural Pharmaceutical …